East Lansing, MI – According to filings with the U.S. Securities and Exchange Commission, GreenMark Biomedical is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Steven Bloembergen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About GreenMark Biomedical

GreenMark Biomedical Inc. is a Michigan-based, minimally invasive healthcare company founded in 2016 by Dr. Steven Bloembergen to pursue dental and medical applications based on a proven starch nanoparticle platform technology. Our mission enable oral healthcare professionals to preserve teeth through earlier diagnosis and noninvasive treatment.

To learn more about GreenMark Biomedical, visit http://greenmark.bio/

Contact:
Steven Bloembergen, Chief Executive Officer
517-896-3665
https://www.linkedin.com/in/steven-bloembergen-10657131/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved